Bausch + Lomb's stock remains a "Hold" despite the latest financial results. Here's what investors need to keep in mind.

For the first nine months of 2025, LTG delivered stronger topline performance with consolidated revenue rising 3.7 percent to ...

Explains when director cash infusions qualify as current account transactions and why genuine business support may fall ...

A key lesson was to measure what matters. From the outset, we defined clear success metrics—latency reduction, resource ...